{
  "item1": null,
  "item7": "Selling, general & administrative (“SG&A”) expenses increased amount, but decreased percentage net sales 2024 compared 2023. increase expenses due selling distribution costs variable expenses which increase net sales increase. addition, SG&A expense increased due higher bad debt-related charges driven bankruptcy significant U.S. healthcare system, higher instrument-related costs due new product introductions, higher litigation-related charges, gain recognized 2023 sale asset which did not recur 2024, higher spending various strategic initiatives.",
  "item2": null
}